PCL Buttock Injections
Ingredient: 331mg/ml polycaprolactone, Sodium carboxymethyl cellulose, Glycerin, Sodium chloride, Phosphate buffer
Specification: 1ml
Package: Single package
Application Area: Used for subcutaneous deep injection of nasal base, nasolabial groove, nose, jaw, eyebrow arch, outer contour, etc.
Product Introduction:
The osmotic pressure of our product ranges from 200-400 mOsm/kg, significantly lower than the 600 mOsm/kg found in most marketed products. This physiologically closer osmotic pressure helps minimize post-injection swelling and redness, improving patient comfort.
Our product also requires less injection force, making it easier to administer. This ensures a smoother, faster treatment experience for both doctors and patients, ultimately reducing procedure duration.
Thanks to its superior viscoelastic properties, our product has demonstrated excellent improvement effects on the nasal base, brow ridge, and outer facial contour.
Product Display:
Product Details:
Type | |
Ingredient | 331mg/ml polycaprolactone, sodium carboxymethyl cellulose, glycerin, sodium chloride, phosphate buffer |
Specification | 1ml |
Effect area | Deep dermis |
Application area | Used for subcutaneous deep injection of nasal base, nasolabial groove, nose, jaw, eyebrow arch, outer contour, etc |
How to choose | Moderate to severe naso-lip wrinkles |
Package | Single package |
Storage | Cool, dry environment |
Recommended | 1-2 pc/time |
Recommended interval | 12 months |
Lasting time | 12 months |
Microsphere size | 25-50μm |
Extruding force | 12N |
Product Package:
Product Effects:
Customer Feedback:
Raw Material Advantages:
1. Our product has an elastic modulus of 350Pa, which is higher than the 180Pa of marketed products, providing superior viscoelasticity. This results in more defined shaping and filling effects while reducing the risk of displacement.
2. With an HA content of 20-24 mg/g, our product offers a greater variety of options and can be customized based on user needs.
3. Due to differences in microsphere types, the degradation time and rate are determined by the properties of the microspheres. Polycaprolactone (PCL) microspheres have a longer duration of action compared to block copolymer microspheres, ensuring more prolonged results.
With a wider range of applications, our product has been shown to effectively improve areas such as the nose, jawline, tear troughs, and temples.
Development Process:
Company Introduction:
Our medical-grade material modification and functionalization platform is backed by 15 years of expertise in polysaccharide material modification and crosslinking, enabling the transformation of chitosan into carboxymethyl chitosan (commercially available as an anti-adhesion surgical solution) and sodium hyaluronate into crosslinked sodium hyaluronate, utilizing advanced biphasic, monophasic, and micro-crosslinking techniques. Additionally, our medical-grade microsphere preparation technology encompasses crosslinked starch microspheres (already commercialized as a composite microporous polysaccharide hemostatic powder), solvent-free injectable PCL, innovative emulsification-based injectable PLLA, and precision-engineered injectable PMMA microspheres.
Factory Equipment: